Our analysis revealed 4483 ligand/receptor pairs, in which the expression levels of ligands and receptors of CD14 + and/or interacting partners in the aforementioned cell types were significantly different between severe COVID-19 patients and HDs, suggesting changes in the interaction of the corresponding immune cells (Additional file 12. The gene discussed is CD14; the disease is COVID-19.